Articles with public access mandates - Artur SlupianekLearn more
Available somewhere: 11
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
K Cramer-Morales, M Nieborowska-Skorska, K Scheibner, M Padget, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1293-1304, 2013
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations
T Stoklosa, T Poplawski, M Koptyra, M Nieborowska-Skorska, G Basak, ...
Cancer research 68 (8), 2576-2580, 2008
Mandates: US National Institutes of Health
BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair
K Cramer, M Nieborowska-Skorska, M Koptyra, A Slupianek, ...
Cancer research 68 (17), 6884-6888, 2008
Mandates: US National Institutes of Health
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress
M Koptyra, K Cramer, A Slupianek, C Richardson, T Skorski
Leukemia 22 (10), 1969-1972, 2008
Mandates: US National Institutes of Health
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells
M Nieborowska-Skorska, K Sullivan, Y Dasgupta, ...
The Journal of clinical investigation 127 (6), 2392-2406, 2017
Mandates: US National Institutes of Health, Austrian Science Fund, Canadian Institutes …
BCR/ABL stimulates WRN to promote survival and genomic instability
A Slupianek, T Poplawski, SK Jozwiakowski, K Cramer, D Pytel, ...
Cancer research 71 (3), 842-851, 2011
Mandates: US National Institutes of Health
The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells
A Slupianek, S Yerrum, FF Safadi, MA Monroy
Journal of cellular physiology 224 (2), 369-375, 2010
Mandates: US National Institutes of Health
Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia
A Slupianek, Y Dasgupta, S Ren, E Gurdek, M Donlin, ...
Blood, The Journal of the American Society of Hematology 118 (4), 1062-1068, 2011
Mandates: US National Institutes of Health
BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability
A Slupianek, R Falinski, P Znojek, T Stoklosa, S Flis, V Doneddu, D Pytel, ...
Leukemia 27 (3), 629-634, 2013
Mandates: US National Institutes of Health
Induction of transcriptional inhibitor HES1 and the related repression of tumor-suppressor TXNIP are important components of cell-transformation program imposed by oncogenic …
Q Zhang, HY Wang, A Nayak, S Nunez-Cruz, A Slupianek, X Liu, ...
The American Journal of Pathology 192 (8), 1186-1198, 2022
Mandates: US National Institutes of Health
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
W Wiese, J Barczuk, O Racinska, N Siwecka, W Rozpedek-Kaminska, ...
Cancers 15 (21), 5297, 2023
Mandates: National Science Centre, Poland
Publication and funding information is determined automatically by a computer program